Overall Survival of Patients With ALK-Positive Metastatic Non–Small-Cell Lung Cancer in the Russian Federation: Nationwide Cohort Study

Overall Survival of Patients With ALK-Positive Metastatic Non–Small-Cell Lung Cancer in the Russian Federation: Nationwide Cohort Study

PURPOSE: The overall survival (OS) results in patients with ALK-positive metastatic non–small-cell lung cancer (NSCLC) have rarely been reported. The aim of this prospective-retrospective cohort study was to obtain real-world data on the use of crizotinib or chemotherapy in patients with ALK-positiv...

Full description

Bibliographic Details
Main Authors: Ilya Tsimafeyeu, Fedor Moiseenko, Sergei Orlov, Elena Filippova, Alexander Belonogov, Aleksey Nebesnykh, Amir Khalimov, Elena Karabina, Valentina Shikina, Ahmed Abdelgafur, Galina Statsenko, Irina Titova, Dmitry Isaichikov, Galina Makarnyaeva, Aleksey Mordovskiy, Oksana Barkovskaya, Aleksey Smirnov, Marina Gikalo, Nikita Savelov, Dmitry Kosov, Evgeny Imyanitov, Irina Demidova, Sergei Tjulandin
Format: Article
Language:English
Published: American Society of Clinical Oncology 2019-05-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.19.00024

Internet

http://ascopubs.org/doi/10.1200/JGO.19.00024

Similar Items